• Latest Posts

Swiss Parkinson’s Biotech raises Massive €29M in Series B from Top European VCs

In Depth 31 Jan 2017

Biologicals on the Brain: Biotech in Neurodegenerative Disease

‘Trojan Horse’ Shark Antibodies could beat the Blood Brain Barrier

An EU Project will tackle Multiple Sclerosis using Personalized Multi Omics

Evotec closes the year partnering with Celgene to treat Alzheimer’s

Following Eli Lilly’s Failure, what’s Next in Alzheimer’s Treatments?


European Pharma closes 2016 by launching new Biotech Startups

Meet the Newest ALS Pioneer Company from Switzerland

UPDATE: More Good News on a Cannabis Derivative for Epilepsy

Drugging the Undruggable: New Acquisition to Boost GPCR Drugs

Here comes the First-ever Combination Therapy for Multiple Sclerosis

New Partnership comes to the Rescue in Neurological Diseases